Clinical Trial Update: Lipitor as a Treatment for Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Lipitor (atorvastatin) for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Institute for the Study of Aging (ISOA) | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED